Learning from skeletal muscles to develop new treatments for cancer
-
Associate Professor Paul Gregorevic+61 3 9035 7700
Project Details
Patients with cancer frequently succumb to complications arising from cachexia, a condition characterised by debilitating loss of functional muscle mass, and adipose tissue. This research program is examining the mechanisms involved in the development of cachexia in the hopes of helping to develop new therapeutic strategies. Another significant factor in cancer morbidity and mortality is the spread of tumour cells to other sites distant from the tissue of origin. However, the colonisation of metastatic cancers within muscle is remarkably infrequent, and the mechanisms underlying these discrepancies between muscle and other tissues remain unclear.
This research is examining why skeletal muscles are comparatively resistant to the propagation of metastatic cancers.
Researchers
A/Prof Paul Gregorevic, Head of Laboratory
Dr Rachel Thomson, Senior Research Assistant
Students
Alastair Saunders, PhD
Research Opportunities
This research project is available to Honours students to join as part of their thesis.
Please contact the Research Group Leader to discuss your options.
Research Publications
View A/Professor Gregorevic's latest PubMed publications listing here
Research Group
Gregorevic laboratory: Muscle Research and Therapeutics
Faculty Research Themes
School Research Themes
Cancer in Biomedicine, Biomedical Neuroscience, Molecular Mechanisms of Disease, Cell Signalling, Therapeutics & Translation
Key Contact
For further information about this research, please contact the research group leader.
Department / Centre
MDHS Research library
Explore by researcher, school, project or topic.